Category: Clinical platform

FDA has authorized a phase III Clinical Trial for Nolasiban

The pivotal US Clinical Trial (IMPLANT 3) will evaluate Nolasiban’s efficacy in women undergoing embryo transfer (ET) following in-vitro fertilization (IVF)

Read More

Clinical Trials for cancer drugs: the challenge of including disparity

Although“… there has been awareness regarding disparity”, as explained by Dr. Jonathan Loree, the lack of ethnic diversity in clinical trials for cancer drugs should be considered more thoroughly by the scientific community.

Read More

Carcik the Italian CAR-T modified therapy

A Phase I/Phase II Clinical Trial is ongoing to test the Italian version Car-T therapy, called Carcik, aimed at treating LLA – Acute Lymphoblastic Leukemia - at the San Gerardo Hospital in Monza and at the Papa Giovanni XIII Hospital in Bergamo.

Read More

It’s now the turn of CRISPR. The first Clinical Trial soon

The first Clinical Trial will be starting to test the gene-editing technique CRISPR in the United States this Fall.

Read More

Breast Cancer Diagnosis: an AI-based model system

A new deep learning model, developed by a team from MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL) and Massachusetts General Hospital (MGH), is attempting to detect patients at risk of breast cancer at an early stage, before the development of the disease, avoiding later diagnosis.

Read More

Are you depressed? Just a click on your phone can reveal it

The days when mobile phones were “simply” a tool used to connect people distant in space, seem so far away. A novelty that eradicates once again this definition, now outdated, is launched by a startup from Palo Alto, California.

Read More

Muscle function and physical performance’s health claims: an EFSA update

Following a request by EFSA, the Panel on Nutrition, Novel Foods and Food Allergens has recently updated the scientific requirements for health claims related to muscle function and physical performance, originally published in 2012.

Read More